Teva stock recovered Wednesday on surprisingly light guidance for 2026 following a decisive fourth-quarter beat.

Teva Pharmaceutical is one of the leading global generic drug manufacturers. By our estimate, roughly 70% of its total revenue is derived from generics and off-patent branded drugs. Generic drugs in ...

Both ANI Pharmaceuticals ANIP and Teva Pharmaceuticals TEVA operate in the pharmaceutical sector, focusing on generic and specialty medications. ANIP’s operations are split between rare disease ...

-- Product: All strengths of Teva Octreotide for Injectable Suspension Kit (DIN 02503751, 02503778 and 0253786) with the lot numbers noted below. -- Issue: Health products -- Product quality -- What ...

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Royalty Pharma plc (NASDAQ: RPRX) announced on Sunday a funding agreement of up to $500 million to accelerate the clinical development of Teva’s ...

The FTC investigation prompted Teva to request the removal of patents from Orange Book, paving the way for generic competition. The removals of more than 200 improper listings will pave the way for ...

Teva Pharmaceutical is one of the world's largest generic drug companies. Teva is working to differentiate itself in generics by focusing on harder-to-produce drugs. Teva has begun manufacturing its ...

Shares of Sagimet Biosciences (SGMT) climbed on Wednesday after the company reached a license agreement with a subsidiary of Teva (TEVA) to target the active pharmaceutical ingredient (API) of ...